Legend Biotech (LEGN) Appoints Peter Salovey to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors
August 8, 2024 4:05 PM EDTSOMERSET, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Peter Salovey, Ph.D., President Emeritus of Yale University, to its Board of Directors. Dr. Salovey will serve as an independent director, effective August 9.
We are pleased to welcome Dr. Salovey to the Legend Board, said Ying Huang, Ph.D., Chief Executive Officer of Legend Biotech. Dr. Saloveys deep experience and wealth of knowledge in medical research and public health will be invaluable to... More



